The role of polyunsaturated fatty acids in term and preterm infants and breastfeeding mothers

Pediatric Clinics of North America

Volumn 48, Issue 1, 2001, Pages 173-188

  Heird, William C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID;

ADULT; ARTIFICIAL MILK; BRAIN DEVELOPMENT; BRAIN FUNCTION; BREAST FEEDING; BREAST MILK; COGNITION; HUMAN; INFANT; LACTATION; LIPOGENESIS; MATERNAL NUTRITION; PREMATURITY; REVIEW; SCORING SYSTEM; VISUAL ACUITY;

EID: 0035123104     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(05)70292-3     Document Type: Article

References (77)

1. Developmental quotient at 24 months and fatty acid composition of diet in early infancy: A follow up study
2. Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice: The role of long-chain polyunsaturated fatty acids
3. Visual acuity, erythrocyte fatty acid composition, and growth in term infants fed formulas with long chain polyunsaturated fatty acids for one year
4. Membrane fatty acids associated with the electrical response in visual excitation
5. Dietary essential fatty acid supply and visual acuity development
6. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants
7. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants
8. Preclinical evaluation of single-cell oils that are highly enriched with arachidonic acid and docosahexaenoic acid
9. Function of dietary polyunsaturated fatty acids in the nervous system
10. Lipid requirements of very-low-birth-weight infants for optimal growth and development
11. Long-term feeding of formulas high in linolenic acid and marine oil to very low birth weight infants: Phospholipid fatty acids
12. First year growth of preterm infants fed standard compared to marine oil ω-3 supplemented formula
13. Visual acuity and fatty acid status of term infants fed human milk and formulas with and without docosahexaenoate and arachidonate from egg yolk lecithin
14. Lower incidence of necrotizing enterocolitis in infants fed a preterm formula with egg phospholipids
15. Docosahexaenoic acid status of preterm infants at birth and following feeding with human milk or formula
16. A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until two months
17. Arachidonic acid status correlates with first year growth in preterm infants
18. Long chain fatty, acids and early visual and cognitive development of preterm infants
19. Visual acuity development in healthy, preterm infants: Effect of marine oil (fish oil) supplementation
20. Effect of long-chain n3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia
21. The very low birth weight premature infant is capable of synthesizing arachidonic and docosahexaenoic acids from linoleic and linolenic acids
22. Intestinal absorption of long-chain polyunsaturated fatty, acids in preterm infants fed breast milk or formula
23. Essential fatty acid interconversion in the human fetal liver
24. Extrauterine fatty acid accretion in infant brain: Implications for fatty acid requirements
25. Intrauterine fatty, acid accretion rates in human brain: Implications for fatty acid requirements
26. Assessment of the efficacious dose of arachidonic and docosahexaenoic acids in preterm infant formulas: Fatty, acid composition of erythrocyte membrane lipids
27. Polyunsaturated fatty acid regulation of hepatic gene transcription
28. Growth, fatty acid composition of plasma lipid classes, and plasma retinol and α-tocopherol concentrations in full-term infants fed formula enriched with ω6 and ω3 long-chain polyunsaturated fatty acids
29. 13C content
30. Infant recognition memory as a measure of intelligence
31. Infant cerebral cortex phospholipid fatty-acid composition and diet
32. Influence of feeding artificial-formula milks containing docosahexaenoic and arachidonic acids on the postnatal long-chain polyunsaturated fatty acid status of healthy preterm infants
33. Effect of increasing breast milk docosahexaenoic acid on plasma and erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants
34. Biological effects and safety issues related to long-chain polyunsaturated fatty acids in infants
35. Docosahexaenoic acid and the development and function of the infant retina
36. Arachidonate and docosahexanoate added to infant formula influence fatty acid composition and subsequent eicosanoid production in neonatal pigs
37. Essential fatty acids in growth and development
38. Visual acuity and blood lipids in term infants fed human milk or formulae
39. Blood lipid docosahexaenoic and arachidonic acid in term gestation infants fed formulas with high docosahexaenoic acid, low eicosapentaenoic acid fish oil
40. Feeding formula without arachidonic acid and docosahexaenoic acid has no effect on preferential looking acuity or recognition memory in healthy full-term infants at 9 mo of age
41. Biochemical effects of dietary linoleic/and α-linolenic acid ratio in term infants
42. Effect of 18:3ω3 intake on plasma fatty acids, growth and visual development of preterm infants
43. Effect of docosahexaenoic acid supplementation of lactating women on the fatty, acid composition of breast milk lipids and maternal and infant plasma phospholipids
44. Effects of docosahexaenoic acid supplementation on visual function and growth of breast-fed term infants
45. Effects of maternal docosahexaenoic acid (DHA) supplementation on visual and neurodevelopmental function of breast-fed infants and indices of maternal depression and cognitive interference
46. Effect of dietary linoleic/alpha-linolenic acid ratio on growth and visual function of term infants
47. Visual acuity and erythrocyte docosahexaenoic acid status in breast-fed and formula-fed term infants during the first four months of life
48. Effect of formula supplemented with docosahexaenoic acid and γ-linolenic acid on fatty, acid status and visual acuity in term infants
49. Long-chain polyunsaturated fatty acids, infant feeding and cognitive development
50. Efficacy and safety of long-chain polyunsaturated fatty acid supplementation of infant-formula milk: A randomised trial
51. Early diet in preterm babies and developmental status at 18 months
52. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants
53. Effect of maternal docosahexaenoic acid (DHA) supplementation on breast milk composition
54. A critical appraisal of the role of dietary long-chain polyunsaturated fatty, acids on neural indices of term infants: A randomized, controlled trial
55. Erythrocyte fatty, acids of term infants fed either breast milk, standard formula, or formula supplemented with long-chain polyunsaturates
56. Are long-chain polyunsaturated fatty acids essential nutrients in infancy?
57. Tissue levels of polyunsaturated fatty acids during early human development
58. Grating acuity cards: Validity and reliability in studies of human visual development
59. Long-chain polyunsaturated fatty acids and the measurement and prediction of intelligence (IQ)
60. Breastfeeding and cognitive development in the first 2 years of life
61. Stereospecific analysis of triacylglycerols rich in long-chain polyunsaturated fatty acids
62. Biochemical and functional effects of prenatal and postnatal ω3 fatty acid deficiency on retina and brain in rhesus monkeys
63. Dietary omega-3 fatty acid deficiency and visual loss in infant rhesus monkeys
64. Dietary fats, membrane phospholipids and obesity
65. Docosahexaenoic acid status of term infants fed breast milk or infant formula containing soy oil or corn oil
66. Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants
67. Meta-analysis of dietary essential fatty acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy preterm infants
68. Dietary essential fatty acids, long-chain polyunsaturated fatty acids, and visual resolution acuity in healthy fullterm infants: A systematic review
69. Lipids of the nervous tissue: Composition and metabolism
70. Intermediates in endogenous synthesis of C22:6ω3 and C20:4ω6 by term and preterm infants
71. Prostanoid formation during feeding of a preterm formula with long-chain polyunsaturated fatty acids in healthy preterm infants during the first weeks of life
72. Effect of dietary omega-3 fatty acids on retinal function of very-low-weight neonates
73. Safety and efficacy of omega-3 fatty acids in the nutrition of very-low-birth-weight infants: Soy oil and marine oil supplementation of formula
74. Long chain polyunsaturated fatty acid formation in neonates: Effect of gestational age and intrauterine growth
75. Evaluation of a long-chain polyunsaturated fatty acid supplemented formula on growth, tolerance, and plasma lipids in preterm infants up to 48 weeks postconceptional age
76. A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until nine months
77. Visual membranes: Specificity of fatty acid precursors for the electrical response to illumination